Glimepirid Aristo (Glimepiride)

Glimepirid Aristo is prescribed as part of a comprehensive diabetes management plan. It is typically used when diet, exercise, and other oral agents are insufficient to achieve glycaemic control.

• Adjunct to diet and exercise in type 2 diabetes mellitus.
• May be combined with metformin or other antidiabetic agents.
• Used when monotherapy with other sulfonylureas is inadequate.
• Considered for patients with stable renal function.
• Often selected for its once‑daily dosing convenience.

Glimepirid Aristo can cause a range of side effects, most of which are mild and transient. Serious reactions are less common but require immediate medical attention.

Common

• Hypoglycaemia (low blood sugar).
• Headache.
• Nausea or abdominal discomfort.
• Dizziness.
• Weight gain.
• Skin rash or itching.

Serious

• Severe hypoglycaemia with loss of consciousness.
• Allergic reactions such as swelling of the face, lips, or throat.
• Hepatic dysfunction indicated by jaundice.
• Hematologic abnormalities like neutropenia.

Before starting Glimepirid Aristo, certain health considerations should be reviewed to minimise risks.

• Assess renal and hepatic function; dose adjustments may be needed.
• Use caution in elderly patients due to increased hypoglycaemia risk.
• Avoid in patients with known sulfonylurea hypersensitivity.
• Monitor blood glucose regularly, especially during dose changes.
• Counsel patients on recognizing and managing hypoglycaemia.
• Discuss pregnancy and lactation status; safety data are limited.

Glimepirid Aristo may interact with several drug classes, affecting its efficacy or safety profile.

Avoid

• Other sulfonylureas or insulin, which can potentiate hypoglycaemia.
• Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that increase glimepiride levels.
• MAO‑B inhibitors, which may enhance hypoglycaemic effects.

Use with caution

• Beta‑blockers, which may mask hypoglycaemia symptoms.
• Thiazide diuretics, potentially raising blood glucose.
• Corticosteroids, which can reduce antidiabetic effectiveness.
• Alcohol, as it may potentiate hypoglycaemia.